soul trial oral semaglutide cardiovascular outcomes results 2024 nejm The impact of on events in patients with type 2 diabetes: review of from the Emily Kronau, PharmD, MBA (@Phar_em_D)

Heres a breakdown of when semaglutide drugs received FDA approval and for what reasons: Since 2017, semaglutide has become one of the 100 most popular prescription drugs in the US, according to Pew Research

HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor

Always inject at a 90-degree angle to avoid injecting into the muscle and prevent medication leakage

Compared with nonusers, adults taking GLP-1s had a: 17 percent lower risk of venous thromboembolism, or blood clots in the veins 31 percent lower risk of pulmonary embolism, a potentially life-threatening clot that travels to the lungs 21 percent lower risk of going to the emergency department 44 percent lower risk of all-cause mortality (death from any cause) Researchers also observed lower stroke rates among GLP-1 users, although this difference didnt reach statistical significance